1. Home
  2. CHGA vs PRFX Comparison

CHGA vs PRFX Comparison

Compare CHGA & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Change Agents Corporation Common Stock

CHGA

Change Agents Corporation Common Stock

N/A

Current Price

$0.22

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$1.05

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHGA
PRFX
Founded
N/A
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.6M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
CHGA
PRFX
Price
$0.22
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.7K
171.8K
Earning Date
N/A
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
33.18
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.58
52 Week High
$0.24
$5.39

Technical Indicators

Market Signals
Indicator
CHGA
PRFX
Relative Strength Index (RSI) 43.78 42.47
Support Level $0.18 $0.97
Resistance Level $0.23 $1.25
Average True Range (ATR) 0.02 0.11
MACD 0.00 0.02
Stochastic Oscillator 65.75 20.15

Price Performance

Historical Comparison
CHGA
PRFX

About CHGA Change Agents Corporation Common Stock

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: